De Freese v. United States, 17457.

Citation270 F.2d 737
Decision Date04 November 1959
Docket NumberNo. 17457.,17457.
PartiesSamuel J. DE FREESE, Appellant, v. UNITED STATES of America, Appellee.
CourtUnited States Courts of Appeals. United States Court of Appeals (5th Circuit)

Arthur D. Herrick, New York City, for appellant.

Frank O. Evans, U. S. Atty., Floyd M. Buford, Asst. U. S. Atty., Macon, Ga., for appellee. Alvin L. Gottlieb, William J. Risteau, Attys., Dept. of Health, Education, and Welfare, Washington, D. C., J. Robert Sparks, Asst. U. S. Atty., James W. Dorsey, U. S. Atty., Atlanta, Ga., of counsel.

Before JONES, BROWN, and WISDOM, Circuit Judges.

WISDOM, Circuit Judge.

The appellant, Samuel J. DeFreese, a physician, was indicted for violation of the Federal Food, Drug, and Cosmetic Act. 21 U.S.C.A. § 301 et seq. He was tried before a jury and found guilty on each of three counts. We affirm the conviction.

Counts one and two of the information charged Dr. DeFreese with dispensing, without a prescription, dl-amphetamine1 sulphate tablets in a bulk container. The third count charged Dr. DeFreese with a sale of phenobarbital tablets2 without a prescription. The information alleged that these drugs had been shipped in interstate commerce; that the sales were in violation of 21 U.S.C.A. §§ 353(b) (1) and 331(k).

The appellant practices in Monroe, Georgia. Wilbur R. Sumrall, Jr., an inspector for the Food and Drug Administration, approached Dr. DeFreese on August 7, 1957 and inquired about purchasing 20,000 "bennies" (benzedrine tablets). Sumrall posed as a truck driver and a "pusher" or salesman of dl-amphetamine sulphate tablets. They drove to appellant's office in Monroe, Georgia. Appellant weighed out approximately 20,000 tablets on a scale and gave them to Sumrall. Sumrall paid him $200 for the tablets.

Dr. DeFreese did not give Sumrall a physical examination nor did he consider Sumrall as a patient. He told Sumrall, in case he should be caught, to say that the tablets were "just aspirin tablets". Sumrall had a concealed portable wire recorder that recorded his conversation with DeFreese.

On August 22, 1957, Sumrall, accompanied by another inspector for the Food and Drug Administration, made a second purchase of 20,000 dl-amphetamine sulphate tablets (Count two). He purchased also 1,000 phenobarbital tablets (Count three). In each case the amphetamine tablets were packed in a bulk container and bore labeling setting forth all the statutory information required by the Federal Food, Drug, and Cosmetic Act, including the name of the manufacturer, the name of the drug, the quantity of tablets, the strength of each tablet, dosage, the generally accepted warnings against misuse, and the prescription legend to the effect that federal law prohibited its dispensing without prescription. The phenobarbital was repackaged and did not bear a label when sold.

I.

The appellant contends, first, that the government failed to prove that the phenobarbital had been shipped in interstate commerce. 21 U.S.C.A. § 331 (k).

The government's proof of interstate shipment consisted of showing that the tablets were manufactured in a state other than Georgia, where they were sold. Dr. Albert H. Tillson, a micro-analyst employed by the Food and Drug Administration, testified that on the basis of scientific examination, microscopic markings, comparison with samples, and by other means, he determined that the tablets were manufactured by Excel Pharmacal Company of New York. This company has only one laboratory and it is located in New York City. The manager of Excel Company denied any sale to DeFreese.

After an interstate shipment, it is immaterial when or how Dr. DeFreese obtained the drugs. United States v. Sullivan, 1948, 332 U.S. 689, 68 S.Ct. 331, 92 L.Ed. 297; Archambault v. United States, 10 Cir., 1955, 224 F.2d 925. Since the tablets were manufactured outside the state of Georgia and sold by Dr. DeFreese in Georgia, the inference is inescapable that there was an interstate shipment.

On appeal, but not during the trial, appellant makes the objection that it is impossible to tell whether Dr. Tillson testified as an expert or as one familiar with the facts; that his testimony was unscientific and entitled to no weight. The record discloses that Dr. Tillson has obtained three degrees in chemistry, belongs to an honorary scientific fraternity, and has had several articles published on microanalysis. His duties involve microscopic examination of foods and drugs in order to identify the ingredients and the manufacturing source of drug tablets. Whether a witness qualifies as an expert rests within the discretion of the trial court. Wharton, Criminal Evidence § 968 (11th ed. 1935). Here, there is no doubt that Dr. Tillson testified as an expert and that his testimony was admissible to show that the tablets were manufactured outside of Georgia. Aeby v. United States, 5 Cir., 1953, 206 F.2d 296, certiorari denied 346 U.S. 885, 74 S.Ct. 136, 98 L.Ed. 390, rehearing denied 346 U.S. 917, 74 S.Ct. 273, 98 L.Ed. 413. No evidence was offered to contradict Tillson's method of identification. The jury deemed it sufficient to establish interstate shipment. There is substantial evidence to sustain the jury's verdict.

II.

The appellant attempts to drag in the Jencks case, infra, contending that the government should have furnished a machine for him to play back the wire recorder.

Sumrall testified that he had concealed on his person a Minifone electronic wire recorder on which was recorded his conversation with DeFreese. Appellant's counsel moved for the agent's "entire file and findings about Dr. DeFreese" for the purpose of impeachment and questioning, including the wire recording. Over objection of government counsel, relying on 18 U.S.C.A. § 3500,3 the district court ruled that appellant's counsel was entitled to hear the recording. The recording was not played before the jury; it was played in chambers.

Later, it was brought out on cross-examination that the original wire recording had not been delivered. Instead,...

To continue reading

Request your trial
9 cases
  • United States v. Wysocki, 71-1663.
    • United States
    • United States Courts of Appeals. United States Court of Appeals (5th Circuit)
    • April 10, 1972
    ...discretion in passing upon the qualifications of an expert. Wolford v. United States, 401 F.2d 331 (10th Cir. 1968); DeFreese v. United States, 270 F.2d 737 (5th Cir. 1959) cert. denied 362 U.S. 944, 80 S.Ct. 810, 4 L.Ed.2d 772 (1960). Witnesses of proved experience in a trade or business w......
  • White v. United States
    • United States
    • United States Courts of Appeals. United States Court of Appeals (8th Circuit)
    • July 9, 1968
    ...health (Tr. 15)." In accord with the decision in Brown, supra, are State v. Bridges (Mo.), 398 S.W.2d 1 (1966); and De Freese v. United States, 270 F.2d 730 (5 Cir. 1959). Support for this conclusion is found in Jin Fuey Moy v. United States, 254 U.S. 189, 194, 41 S.Ct. 98, 65 L.Ed. 214 (19......
  • De Freese v. United States
    • United States
    • United States Courts of Appeals. United States Court of Appeals (5th Circuit)
    • November 4, 1959
  • Palmer v. United States
    • United States
    • United States Courts of Appeals. United States Court of Appeals (5th Circuit)
    • December 7, 1964
    ...merit to this contention. A microanalyst testified that the drugs were manufactured in Greenville, South Carolina. In DeFreese v. United States, 5 Cir. 1959, 270 F.2d 737, cert. den'd 362 U.S. 944, 80 S.Ct. 810, 4 L.Ed.2d 772, we held that such testimony of an expert was sufficient in itsel......
  • Request a trial to view additional results

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT